» Articles » PMID: 25713764

Helicobacter Cinaedi Infection in Patients with Diabetes: a Case Report

Overview
Journal Springerplus
Date 2015 Feb 26
PMID 25713764
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Helicobacter cinaedi causes bacteremia without characteristic clinical symptoms and is firstly isolated from human immunodeficiency virus (HIV)-positive homosexual men.

Findings: Here we describe, for the first time case report, two female patients with diabetes who had H. cinaedi bacteremia. Some cases of H. cinaedi bacteremia may require long-term administration of multiple antibiotics prior to the resolution of infection.

Conclusions: Therefore, these cases indicate that it is important to consider H. cinaedi in patients with diabetes presenting with bacteremia, especially in patients with poor glycemic control.

References
1.
Kawamura Y, Tomida J, Morita Y, Fujii S, Okamoto T, Akaike T . Clinical and bacteriological characteristics of Helicobacter cinaedi infection. J Infect Chemother. 2014; 20(9):517-26. DOI: 10.1016/j.jiac.2014.06.007. View

2.
Totten P, Fennell C, Tenover F, Wezenberg J, Perine P, Stamm W . Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis. 1985; 151(1):131-9. DOI: 10.1093/infdis/151.1.131. View

3.
Rimbara E, Mori S, Matsui M, Suzuki S, Wachino J, Kawamura Y . Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. J Clin Microbiol. 2012; 50(8):2553-60. PMC: 3421485. DOI: 10.1128/JCM.06810-11. View

4.
Araoka H, Baba M, Kimura M, Abe M, Inagawa H, Yoneyama A . Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J Clin Microbiol. 2014; 52(5):1519-22. PMC: 3993694. DOI: 10.1128/JCM.00265-14. View

5.
Murakami H, Goto M, Ono E, Sawabe E, Iwata M, Okuzumi K . Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan. J Infect Chemother. 2003; 9(4):344-7. DOI: 10.1007/s10156-003-0265-3. View